StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by polo11on Dec 08, 2016 6:14pm

79 Views

Post# 25574491

RE:PAC

Of the approximately 9.8 million Units subscribed to, approximately 5.1 million were from new investors and, as described below, 2.5 million were used to retire CAD $400,000 in debt and 0.6 million were in lieu of making a CAD $100,000 cash payment for services rendered.

Mean 4.7 shares was issue to insider

thepbay wrote: Enjoy the 9 million plus share coming free trading first week of Jan. More free DD for you, seeing you cannot do it your self. GL

pbay

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property